RUNX2 and triple-negative breast carcinoma: For the purpose, we verified that RUNX2 knockdown was adequate to inhibit the in vitro proliferation, migration, invasion, and chemoresistance of resistant cells in triple negative breast cancer as well as the tumor growth in BALB/c nude mice.